EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic

AccesswireAug 16, 2023 09:30 ET

EV Biologics Launches Excyte With $100M Valuation

Seeking AlphaAug 15, 2022 15:53 ET

EV Biologics Launches Excyte With $100 Million Valuation

AccesswireAug 15, 2022 09:05 ET

EV Biologics Signs MSA with LONZA Cell & Gene Therapy

AccesswireMay 17, 2022 12:09 ET

EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development

AccesswireApr 12, 2022 09:06 ET

EV Biologics Updates on FINRA Filings

AccesswireMar 9, 2022 09:06 ET